HighTower Advisors LLC Sells 35,569 Shares of Abbott Laboratories $ABT

HighTower Advisors LLC has reduced its stake in Abbott Laboratories, selling 35,569 shares, which now leaves them with 1,838,381 shares valued at approximately $246.2 million. Despite recent price target cuts from some brokerages, Abbott currently holds a consensus “Moderate Buy” rating with an average target price of $137.05. The company recently reported Q4 EPS of $1.50, revenue of $11.46 billion, set FY2026 guidance, and increased its quarterly dividend to $0.63.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)